Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System
NCT: NCT05540223 · ACTIVE_NOT_RECRUITING
Brief Summary
The objective of this study is to assess the safety and efficacy of the Freesolve in the treatment of subjects with up to two de novo lesions in native coronary arteries compared to a contemporary drug eluting stent (DES).
Frequently Asked Questions
What is Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System?
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System is a clinical trial registered under NCT05540223. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05540223?
The current status of NCT05540223 (Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System) is: ACTIVE_NOT_RECRUITING.
When did Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System start?
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System started on 2024-05-13.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.